The CNX IT index has rallied 0.8 percent to 11,708, and the pharma index has slipped marginally a percent at 13,175. The Bank Nifty is down 1.6 percent at 16,867, while the PSU Bank and Realty indices down around 2 percent each.The India VIX (Volatility) index up 4.4% at 25.68.
Posts in category All News
Sensex slips below 26K (01-09-2015)
The CNX IT index has rallied 0.8 percent to 11,708, and the pharma index has slipped marginally a percent at 13,175. The Bank Nifty is down 1.6 percent at 16,867, while the PSU Bank and Realty indices down around 2 percent each.The India VIX (Volatility) index up 4.4% at 25.68.
Rupee advances in late morning deals, up 24 paise vs USD (01-09-2015)
The rupee opened higher at 66.38 per dollar against yesterday's closing level of 66.48 at the Interbank Foreign Exchange (Forex) market.
Sun Pharma surges 1%; announces successful completion of Opiates business (01-09-2015)
The stock opened at Rs.889 against the previous close of Rs. 898 on BSE. It has hit a high of Rs. 915.30 and a low of Rs.883.40 on BSE today.
Buy Majesco; target of Rs 460: BP Equities (01-09-2015)
BP Equities is bullish on Majesco and has recommended buy rating on the stock with a target price of Rs 460, in its research report dated August 28, 2015.
Buy Shilpa Medicare; target of Rs 1140: Firstcall (01-09-2015)
Brokerage house Firstcall Research is bullish on Shilpa Medicare and has recommended buy rating on the stock with a target price of Rs 1140 in its research report dated August 28, 2015.
Lakshmi Vilas Bank cuts interest rates on term deposits (01-09-2015)
The bank has revised its interest rate on Domestic and NRO Term deposits w.e.f from Wednesday taking into account.
Buy National Fittings; target of Rs 85: Firstcall (01-09-2015)
Brokerage house Firstcall Research is bullish on National Fittings and has recommended buy rating on the stock with a target price of Rs 85 in its research report dated August 28, 2015.
Sun Pharma shares gain on completing acquisition of Opiates business in Australia (01-09-2015)
Shares of Sun Pharmaceutical Industries gained over 1.5 per cent in the morning trade on Tuesday after the company announced that it has successfully completed the acquisition of Opiates business in Australia from GSK. (Photo: Reuters)
Shares of Sun Pharmaceutical Industries gained over 1.5 per cent in the morning trade on Tuesday after the company announced that it has successfully completed the acquisition of Opiates business in Australia from GSK. The announcement was made before market hours on Tuesday.
At 11.06 pm, the share price of Sun Pharmaceutical was trading 1.73 per cent higher at Rs 913.20. It opened at Rs 889 and had touched a high and low of Rs 915.30 and 883.40, respectively, in trade so far. The BSE Sensex was down 181.71 points at 26,101.38.
In a BSE filing, the company said, “This acquisition fortifies Sun Pharma’s global position with two Opiates manufacturing facilities in Port Fairy & Latrobe (both in Australia) complementing its current API manufacturing footprint globally.”
Sun Pharma now offers a rich basket of Opiates product line in addition to a large API portfolio and dosage formulations covering a broad range of chronic and acute prescription drugs. The acquisition also brings a specialized team to drive business growth.
For the quarter ended June 2015, the company reported a consolidated net profit of Rs 478.96 crore, down 65.56 per cent against Rs 1,390.51 crore in the corresponding quarter a year ago.
Reduce Den Networks; target of Rs 127: Emkay (01-09-2015)
Brokerage house Emkay Global Financial Services has recommended a reduce rating on Den Networks with a target price of Rs 127 in its research report dated August 11, 2015.
Hold Atul Auto; target of Rs 470: ICICIdirect (01-09-2015)
ICICIdirect.com has recommended to hold Atul Auto with a target price of Rs 470, in its research report dated August 24, 2015.